Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Cytotherapy
|
April 16, 2002
Legal and Regulatory Affairs workshop summary
Donna Przepiorka
Pharmaceutical Statistics
|
April 28, 2021
Using marginal structural models to analyze the impact of subsequent therapy on the treatment effect in survival data: Simulations and clinical trial examples
Qing Xu, Donna Przepiorka
Haematologica
|
April 2, 2026
Implications of the EHA/ELN guidelines for reporting blast percentage. Comment on: "Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel"
Donna Przepiorka, Emily Y Jen
Pharmacotherapy
|
December 25, 2007
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
Donna Przepiorka, Francis K Buadi, Brian McClune
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Acute Myeloid Leukemia Response Measures Other Than Complete Remission
Donna Przepiorka, Albert Deisseroth, Ann T Farrell
JAMA Oncology
|
March 25, 2021
The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making
Donna Przepiorka, R Angelo de Claro, Richard Pazdur
JAMA
|
February 10, 2025
Obecabtagene Autoleucel for B-Cell Acute Lymphoblastic Leukemia
Najat Bouchkouj, Donna Przepiorka, Lola A Fashoyin-Aje
JAMA
|
May 21, 2025
Remestemcel-L-rknd for Steroid-Refractory Acute Graft-vs-Host Disease in Pediatric Patients
Upendra Mahat, Donna Przepiorka, Lola A Fashoyin-Aje
Leukemia & Lymphoma
|
September 6, 2007
Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma
Brian McClune, Francis K Buadi, Naveed Aslam, et al.
Gynecologic Oncology
|
September 19, 2003
Pap smear noncompliance among female obstetrics-gynecology residents
Judith J Williams, Joseph T Santoso, Frank W Ling, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Cytotherapy
|
April 16, 2002
Legal and Regulatory Affairs workshop summary
Donna Przepiorka
Pharmaceutical Statistics
|
April 28, 2021
Using marginal structural models to analyze the impact of subsequent therapy on the treatment effect in survival data: Simulations and clinical trial examples
Qing Xu, Donna Przepiorka
Haematologica
|
April 2, 2026
Implications of the EHA/ELN guidelines for reporting blast percentage. Comment on: "Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel"
Donna Przepiorka, Emily Y Jen
Pharmacotherapy
|
December 25, 2007
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
Donna Przepiorka, Francis K Buadi, Brian McClune
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Acute Myeloid Leukemia Response Measures Other Than Complete Remission
Donna Przepiorka, Albert Deisseroth, Ann T Farrell
JAMA Oncology
|
March 25, 2021
The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making
Donna Przepiorka, R Angelo de Claro, Richard Pazdur
JAMA
|
February 10, 2025
Obecabtagene Autoleucel for B-Cell Acute Lymphoblastic Leukemia
Najat Bouchkouj, Donna Przepiorka, Lola A Fashoyin-Aje
JAMA
|
May 21, 2025
Remestemcel-L-rknd for Steroid-Refractory Acute Graft-vs-Host Disease in Pediatric Patients
Upendra Mahat, Donna Przepiorka, Lola A Fashoyin-Aje
Leukemia & Lymphoma
|
September 6, 2007
Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma
Brian McClune, Francis K Buadi, Naveed Aslam, et al.
Gynecologic Oncology
|
September 19, 2003
Pap smear noncompliance among female obstetrics-gynecology residents
Judith J Williams, Joseph T Santoso, Frank W Ling, et al.
Page
of 6